학술논문
S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Document Type
article
Author
Source
HemaSphere, Vol 7, p e15362d7 (2023)
Subject
Language
English
ISSN
2572-9241